ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+10.85%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$37.6B
AUM Growth
+$4.89B
(+15%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
6.23%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
2,051
New
98
Increased
1,226
Reduced
674
Closed
47
Top Buys
| 1 |
NVIDIA
NVDA
|
+$233M |
| 2 |
Linde
LIN
|
+$215M |
| 3 |
Microsoft
MSFT
|
+$210M |
| 4 |
Fastenal
FAST
|
+$199M |
| 5 |
Apple
AAPL
|
+$181M |
Top Sells
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$159M |
| 2 |
Target
TGT
|
+$40.7M |
| 3 |
IBM
IBM
|
+$40.1M |
| 4 |
Sherwin-Williams
SHW
|
+$36.8M |
| 5 |
W.W. Grainger
GWW
|
+$34.9M |
Sector Composition
| 1 | Technology | 28.52% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Staples | 11.58% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Financials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Fox Class B
FOX
$25.8B
| $483K | ﹤0.01% |
16,888
+49
| +0.3% | +$1.4K |
|
1102
MasterBrand
MBC
$1.7B
| $483K | ﹤0.01% |
25,778
+1,486
| +6% | +$27.8K |
|
1103
LPL Financial
LPLA
$28B
| $482K | ﹤0.01% |
1,826
-284
| -13% | -$75K |
|
1104
Amphastar Pharmaceuticals
AMPH
$1.3B
| $482K | ﹤0.01% |
10,973
+708
| +7% | +$31.1K |
|
1105
Avidity Biosciences
RNA
$5.86B
| $482K | ﹤0.01% |
18,878
+1,898
| +11% | +$48.4K |
|
|
EXE
1106
Expand Energy Corporation Common Stock
EXE
$23.1B
| $482K | ﹤0.01% |
5,423
-438
| -7% | -$38.9K |
|
1107
Tetra Tech
TTEK
$9.51B
| $482K | ﹤0.01% |
13,035
-965
| -7% | -$35.6K |
|
1108
Annaly Capital Management
NLY
$14.1B
| $480K | ﹤0.01% |
24,397
-1,908
| -7% | -$37.6K |
|
1109
AMN Healthcare
AMN
$693M
| $480K | ﹤0.01% |
7,678
+529
| +7% | +$33.1K |
|
1110
Syndax Pharmaceuticals
SNDX
$1.35B
| $479K | ﹤0.01% |
20,112
+4,599
| +30% | +$109K |
|
1111
CVB Financial
CVBF
$2.77B
| $478K | ﹤0.01% |
26,820
+1,844
| +7% | +$32.9K |
|
|
SGI
1112
Somnigroup International Inc.
SGI
$17.6B
| $478K | ﹤0.01% |
8,404
-658
| -7% | -$37.4K |
|
1113
Curtiss-Wright
CW
$19.2B
| $477K | ﹤0.01% |
1,865
-147
| -7% | -$37.6K |
|
1114
Core & Main
CNM
$9.36B
| $477K | ﹤0.01% |
8,326
+1,128
| +16% | +$64.6K |
|
1115
Sonos
SONO
$1.82B
| $476K | ﹤0.01% |
24,973
+1,092
| +5% | +$20.8K |
|
1116
Kratos Defense & Security Solutions
KTOS
$11.7B
| $476K | ﹤0.01% |
25,883
+4,765
| +23% | +$87.6K |
|
1117
Rocket Pharmaceuticals
RCKT
$342M
| $475K | ﹤0.01% |
17,614
+1,468
| +9% | +$39.5K |
|
1118
Oceaneering
OII
$2.43B
| $474K | ﹤0.01% |
20,270
+1,394
| +7% | +$32.6K |
|
1119
Flywire
FLYW
$1.64B
| $474K | ﹤0.01% |
19,104
+1,504
| +9% | +$37.3K |
|
1120
Progress Software
PRGS
$1.81B
| $474K | ﹤0.01% |
8,888
+714
| +9% | +$38.1K |
|
1121
Credo Technology Group
CRDO
$27.9B
| $473K | ﹤0.01% |
22,343
+3,346
| +18% | +$70.9K |
|
1122
Strategic Education
STRA
$1.98B
| $473K | ﹤0.01% |
4,544
+309
| +7% | +$32.2K |
|
1123
Supernus Pharmaceuticals
SUPN
$2.55B
| $473K | ﹤0.01% |
13,859
+1,021
| +8% | +$34.8K |
|
1124
Keros Therapeutics
KROS
$640M
| $472K | ﹤0.01% |
7,136
+1,496
| +27% | +$99K |
|
1125
AGCO
AGCO
$8.11B
| $472K | ﹤0.01% |
3,840
-327
| -8% | -$40.2K |
|